Vertex Pharmaceuticals (VRTX) Bullish Elliott Wave Targets $556.9–$646.4

An Elliott Wave forecast for Vertex Pharmaceuticals (VRTX) indicates a bullish continuation, with the next price target zone set at $556.9 – $646.4.

Vertex is a biotechnology company developing treatments for serious diseases across multiple age groups, operating in the U.S., Europe, and internationally. The stock trades under the ticker VRTX in the Healthcare – Biotech sector.

The analysis suggests that the current wave structure supports further upside within the specified range.